Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)1.61
  • Today's Change-0.012 / -0.74%
  • Shares traded34.12k
  • 1 Year change-31.78%
  • Beta0.6972
Data delayed at least 15 minutes, as of Nov 08 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments92101120
Total Receivables, Net463113
Total Inventory------
Prepaid expenses9.077.324.95
Other current assets, total0.00----
Total current assets148140138
Property, plant & equipment, net6.328.5410
Goodwill, net------
Intangibles, net0.421.5644
Long term investments9.803540
Note receivable - long term111430
Other long term assets--0.000.00
Total assets184208267
LIABILITIES
Accounts payable8.561415
Accrued expenses7.025.987.46
Notes payable/short-term debt7.65107.42
Current portion long-term debt/capital leases8.942.1031
Other current liabilities, total7.479.3620
Total current liabilities404180
Total long term debt769347
Total debt9310585
Deferred income tax9.018.575.03
Minority interest------
Other liabilities, total7.661129
Total liabilities132154160
SHAREHOLDERS EQUITY
Common stock4.044.013.98
Additional paid-in capital384380375
Retained earnings (accumulated deficit)(336)(329)(272)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0.00
Total equity5254107
Total liabilities & shareholders' equity184208267
Total common shares outstanding818080
Treasury shares - common primary issue0.020.020.02
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.